Wall St slips as Apple, healthcare stocks drop


Traders work on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., September 28, 2016. REUTERS/Brendan McDermid

NEW YORK: Wall Street was lower in choppy trading late Thursday morning, pulled lower by Apple and healthcare stocks.

The S&P healthcare index fell 0.7%, marking the second straight day of decline as shares of Merck and Johnson & Johnson booked losses.

Apple fell 1.23% after Barclays cut its price target. The stock was the biggest drag on Wall Street.

Investors are awaiting Federal Reserve chair Janet Yellen’s speech in Washington for clues on the timing of the next interest rate hike.

“The markets are taking a step back after a couple of pretty good days,” said Paul Nolte, portfolio manager at Kingsview Asset Management in Chicago.

“It is the end of the quarter so there are people messing around with some positions.”

The three indexes have registered gains in the past two days.

At 11:01am. ET (1501 GMT), the Dow Jones Industrial Average was down 40.85 points, or 0.22%, at 18,298.39.

The S&P 500 was down 4.78 points, or 0.22%, at 2,166.59.

The Nasdaq Composite was down 22.79 points, or 0.43%, at 5,295.75.

Five of the 11 major S&P indexes were lower, with utilities  falling the most by 1.1%. The sector, which is sensitive to interest rates, is on track to mark its fifth day of losses in a row.

Kansas City Fed President and voting member Esther George told CNBC that it was time to move ahead with a rate hike, a stand that Atlanta Fed president Dennis Lockhart echoed.

Oil prices were up 0.4%, after Wednesday’s 6% rally, as investors questioned whether an Opec agreement to curb production would be enough to rebalance a heavily over-supplied market.

ConAgra was the top percentage gainer on the S&P, rising 7.3% after the company’s profit beat analysts’ estimate.

Intra-Cellular plunged 63.2% after the company said its schizophrenia drug did not show any clinically significant difference when compared with placebo.

Ebay rose 3% after Deutsche Bank upgraded the e-commerce platform’s rating to “buy” and raised its price target.

Declining issues outnumbered advancing ones on the NYSE by 1,667 to 1,156. On the Nasdaq, 1,625 issues fell and 995 advanced.

The S&P 500 index showed 19 new 52-week highs and one new lows, while the Nasdaq recorded 52 new highs and 20 new lows. - Reuters


Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

China's largest auto show showcases all-electric future, local brands dominate
Unilever beats first quarter sales forecasts, sticks to 2024 outlook
Oil steady as market weighs US demand concerns, Middle East conflict risks
HeiTech Padu targets stronger earnings growth after returning to black in 2023
PBOC may up bond trading
Rafizi: Govt to share details on subsidy rationalisation mechanism
Deutsche Bank Q1 profit jumps 10% as investment bank outperforms
Stocks hit by tech slide; yen flails at intervention zone
Toyota hits record annual output, sales on robust demand
Solarvest delivers 8.9MWP solar project to NTPM

Others Also Read